Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Pattern and Outcome of Acute Disseminated Encephalomyelitis (ADEM) in Children: Experience in a Tertiary Center, Upper Egypt.
Disease activity in chronic inflammatory demyelinating polyneuropathy.
Effectiveness of intramuscular injections of botulinum toxin in the treatment of disabling cerebellar tremor of the hand.
Analyses on the misdiagnoses of 25 patients with unilateral optic nerve sheath meningioma.
Physical comorbidities increase the risk of psychiatric comorbidity in multiple sclerosis.
Foxo3 Transcription Factor Drives Pathogenic T Helper 1 Differentiation by Inducing the Expression of Eomes.
Treatment of the osmotic demyelination syndrome: the earlier the better?
25-hydroxycholesterol contributes to cerebral inflammation of X-linked adrenoleukodystrophy through activation of the NLRP3 inflammasome.
RAGE-ligand axis: A new biomarker in multiple sclerosis, time for multicentre validation study!
Regional disparities in botulinum toxin A (BoNT-A) therapy for spasticity in Sweden: budgetary consequences of closing the estimated treatment gap.
The effects of whole body vibration on muscle strength and functional mobility in persons with multiple sclerosis: A systematic review and meta-analysis.
Brain atrophy after bone marrow transplantation for treatment of multiple sclerosis.
Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel(®).
Influenza vaccination in patients with multiple sclerosis is possible with some considerations.
Internalization and presentation of myelin antigens by the brain endothelium guides antigen-specific T cell migration.
Knowing what's right: Which analgesic is recommended for a patient suffering from demyelinating polyneuropathy and scheduled for rotator-cuff repair?
Dietary salt intake and time to relapse in paediatric multiple sclerosis.
CTLA4 as Immunological Checkpoint in the Development of Multiple Sclerosis.
New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies.
Loss of Hippocampal Oligodendrocytes Contributes to the Deficit of Contextual Fear Learning in Adult Rats Experiencing Early Bisphenol A Exposure.
Declines in the diagnosis of primary progressive MS: A critical change in phenotype or critical measurement error?
Theoretical predication of temperature effect on conducting processes in simulated amyotrophic lateral sclerosis at 20-40[Formula: see text]C.
Vitamin D and Systemic Lupus Erythematosus: Myth or Reality?
IL-27 plasma level in relapsing remitting multiple sclerosis subjects: The double-faced cytokine.
Commentary: Acute Hemorrhagic Leukoencephalitis (Weston-Hurst Syndrome) in a Patient with Relapse-Remitting Multiple Sclerosis.

Pages